YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation

Journal: Nature Communications

Published: 2020-01-03

DOI: 10.1038/s41467-019-13771-5

Affiliations: 4

Authors: 17

Go to article
Institutions Share
Faculty / Graduate School of Medicine, Kyoto University, Japan 0.65
Faculty / Graduate School of Agriculture, Kyoto University, Japan 0.18
Chugai Pharmaceutical Co., Ltd., Japan 0.12
Graduate School / School of Medicine, Kobe University, Japan 0.06